Literature DB >> 17338737

Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis.

Marian C Aldhous1, Hazel E Drummond, Niall Anderson, M Reza Baneshi, Linda A Smith, Ian D R Arnott, Jack Satsangi.   

Abstract

INTRODUCTION: Cigarette smoking affects susceptibility to ulcerative colitis (UC), but its effects on age at diagnosis, disease extent, and need for surgery are less well defined. We examined these parameters in a detailed retrospective analysis of a large cohort of well-characterized UC patients.
METHODS: 499 UC patients (254 male, median age 34.3 yr) were studied. Data were collected on smoking habits, smoking load (pack-years), age at recruitment, age at diagnosis, surgery, and disease extent. Colonoscopic and histological data at both diagnosis and follow-up (median follow-up time 4.6 yr) were available on 349 patients.
RESULTS: Ex-smokers were older at diagnosis than current or nonsmokers, (46.5 yr vs 31.1 or 29.4 yr, respectively, P < 0.001). Before diagnosis, ex-smokers had a higher smoking load than current smokers (13.0 vs 6.94 pack-years, P < 0.001). A Cox model for age at diagnosis, with smoking as a time-dependent covariate, showed that at any age, ex-smokers were significantly more likely to develop UC than current smokers (hazard ratio 1.8, 95% CI 1.41-2.44, P < 0.001). For current smokers at latest colonoscopy, those with extensive disease were the lightest smokers (median 0.320 pack-years), whereas those with healthy colons were the heaviest smokers (median 9.18 pack-years, P= 0.006). At 5 yr, regression of extensive disease was more frequent in current than ex-smokers or nonsmokers (30% current smokers vs 8% nonsmokers and 5% ex-smokers, chi(2)= 30.4, P < 0.001) but these differences were not maintained over a longer time period.
CONCLUSIONS: Smoking habit influences the age at diagnosis and changes in disease extent in UC. Mechanisms are likely to be complex and require further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17338737     DOI: 10.1111/j.1572-0241.2007.01065.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

1.  Effects of family history on inflammatory bowel disease characteristics in Japanese patients.

Authors:  Erika Kuwahara; Keiko Asakura; Yuji Nishiwaki; Nagamu Inoue; Mamoru Watanabe; Toshifumi Hibi; Toru Takebayashi
Journal:  J Gastroenterol       Date:  2012-03-01       Impact factor: 7.527

Review 2.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 3.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.

Authors:  Sudeep Dhoj Thapa; Hiba Hadid; Mohammed Usman; Waseem Imam; Ahmad Hassan; Jason Schairer; Syed-Mohammed R Jafri; Nirmal Kaur
Journal:  Dig Dis Sci       Date:  2015-10-28       Impact factor: 3.199

5.  Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease.

Authors:  Christina Y Ha; Rodney D Newberry; Christian D Stone; Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-02       Impact factor: 11.382

Review 6.  Gene-environment interactions in inflammatory bowel disease: microbiota and genes.

Authors:  Marian C Aldhous
Journal:  Frontline Gastroenterol       Date:  2012-05-21

7.  Growth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and α and β nicotinamide adenine dinucleotide.

Authors:  Robert J Greenstein; Liya Su; Sheldon T Brown
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

8.  Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease: a multicenter experience.

Authors:  Jumpei Kondo; Hideki Iijima; Takashi Abe; Masato Komori; Satoshi Hiyama; Toshifumi Ito; Akihiro Nakama; Kouhei Tominaga; Mitsuhiko Kubo; Kunio Suzuki; Yoshihisa Iwanaga; Ryoichi Ebara; Akira Takeda; Shingo Tsuji; Tsutomu Nishida; Shusaku Tsutsui; Masahiko Tsujii; Norio Hayashi
Journal:  J Gastroenterol       Date:  2010-02-20       Impact factor: 7.527

9.  Is moderate red wine consumption safe in inactive inflammatory bowel disease?

Authors:  Garth R Swanson; Vanessa Tieu; Maliha Shaikh; Chris Forsyth; Ali Keshavarzian
Journal:  Digestion       Date:  2011-08-26       Impact factor: 3.216

10.  Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.

Authors:  Marian C Aldhous; Colin L Noble; Jack Satsangi
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.